Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease
Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease have?
Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease has 88 citations in the OpenAlex counts ScholarIQ stores.
When was Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease published?
Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease has 2020 year in the ScholarIQ index.
What is the open-access status of Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease?
Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease has bronze oa status in the ScholarIQ index.
What is the DOI of Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease?
The DOI for Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease is on the source record.
What is the PMID of Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease?
The PMID for Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease is on the source record.
What is the OpenAlex record for Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease?
The OpenAlex for Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease is on the source record.